Canada markets close in 2 hours 40 minutes
  • S&P/TSX

    20,116.97
    +125.09 (+0.63%)
     
  • S&P 500

    4,254.16
    +46.89 (+1.11%)
     
  • DOW

    33,618.83
    +282.16 (+0.85%)
     
  • CAD/USD

    0.7828
    -0.0009 (-0.11%)
     
  • CRUDE OIL

    92.08
    -2.26 (-2.40%)
     
  • BTC-CAD

    30,686.70
    -649.89 (-2.07%)
     
  • CMC Crypto 200

    570.08
    -1.20 (-0.21%)
     
  • GOLD FUTURES

    1,817.40
    +10.20 (+0.56%)
     
  • RUSSELL 2000

    2,004.11
    +28.85 (+1.46%)
     
  • 10-Yr Bond

    2.8590
    -0.0290 (-1.00%)
     
  • NASDAQ

    12,965.89
    +185.97 (+1.46%)
     
  • VOLATILITY

    19.21
    -0.99 (-4.90%)
     
  • FTSE

    7,500.89
    +34.98 (+0.47%)
     
  • NIKKEI 225

    28,546.98
    +727.65 (+2.62%)
     
  • CAD/EUR

    0.7622
    +0.0034 (+0.45%)
     

Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conference

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
Biofrontera Inc.
Biofrontera Inc.

WOBURN, Mass., May 31, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in The Benchmark Healthcare House Call Virtual 1x1 Conference being held on June 2, 2022.

Erica Monaco, Chief Executive Officer and Hermann Lübbert, Executive Chairman of Biofrontera Inc. will be meeting with registered investors in virtual one-on-one meetings and small-group sessions.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on PDT and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit https://www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting